Biotech Bonanza: 2023 Biotech Outlook As The Fed Remains Hawkish By: TalkMarkets January 11, 2023 at 05:30 AM EST 2023 can be the year of biotechs after two consecutive years of negative or barely positive returns. Read More >> Related Stocks: 7-10 Year Treasury Bond Ishares ETF Biogen Idec Bristol-Myers Squibb Cassava Sciences Inc Eli Lilly Merck & Co Moderna Inc Pfizer Prothena Corp
